These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20735408)

  • 1. Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).
    Chen XP; Yang W; Fan Y; Luo JS; Hong K; Wang Z; Yan JF; Chen X; Lu JX; Benovic JL; Zhou NM
    Br J Pharmacol; 2010 Dec; 161(8):1817-34. PubMed ID: 20735408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain.
    Zheng C; Chen L; Chen X; He X; Yang J; Shi Y; Zhou N
    PLoS One; 2013; 8(5):e63262. PubMed ID: 23667597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
    Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
    Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential coupling of beta3A- and beta3B-adrenergic receptors to endogenous and chimeric Galphas and Galphai.
    Lenard NR; Prpic V; Adamson AW; Rogers RC; Gettys TW
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E704-15. PubMed ID: 16705062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
    Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M
    Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system.
    Zamah AM; Delahunty M; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2002 Aug; 277(34):31249-56. PubMed ID: 12063255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
    Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
    Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G
    Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ
    Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
    Jarrahian A; Watts VJ; Barker EL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.
    Turu G; Várnai P; Gyombolai P; Szidonya L; Offertaler L; Bagdy G; Kunos G; Hunyady L
    J Biol Chem; 2009 Jun; 284(25):16914-16921. PubMed ID: 19357084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal domain of the Gs-coupled EP4 receptor confers agonist-dependent coupling control to Gi but no coupling to Gs in a receptor hybrid with the Gi-coupled EP3 receptor.
    Neuschäfer-Rube F; Hänecke K; Blaschke V; Jungermann K; Püschel GP
    FEBS Lett; 1997 Jan; 401(2-3):185-90. PubMed ID: 9013884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues mediate G(i) versus G(s) activation.
    Wade SM; Lim WK; Lan KL; Chung DA; Nanamori M; Neubig RR
    Mol Pharmacol; 1999 Nov; 56(5):1005-13. PubMed ID: 10531407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
    Bingham B; Jones PG; Uveges AJ; Kotnis S; Lu P; Smith VA; Sun SC; Resnick L; Chlenov M; He Y; Strassle BW; Cummons TA; Piesla MJ; Harrison JE; Whiteside GT; Kennedy JD
    Br J Pharmacol; 2007 Aug; 151(7):1061-70. PubMed ID: 17549048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector coupling.
    Walsh M; Foley JF; Kinsella BT
    Biochim Biophys Acta; 2000 Apr; 1496(2-3):164-82. PubMed ID: 10771086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
    Obadiah J; Avidor-Reiss T; Fishburn CS; Carmon S; Bayewitch M; Vogel Z; Fuchs S; Levavi-Sivan B
    Cell Mol Neurobiol; 1999 Oct; 19(5):653-64. PubMed ID: 10384262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.